{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33270653",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "02",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "12",
        "Day": "03"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e1008449",
      "10.1371/journal.pcbi.1008449"
    ],
    "Journal": {
      "ISSN": "1553-7358",
      "JournalIssue": {
        "Volume": "16",
        "Issue": "12",
        "PubDate": {
          "Year": "2020",
          "Month": "Dec"
        }
      },
      "Title": "PLoS computational biology",
      "ISOAbbreviation": "PLoS Comput Biol"
    },
    "ArticleTitle": "Insights on cross-species transmission of SARS-CoV-2 from structural modeling.",
    "Pagination": {
      "StartPage": "e1008449",
      "MedlinePgn": "e1008449"
    },
    "Abstract": {
      "AbstractText": [
        "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing global pandemic that has infected more than 31 million people in more than 180 countries worldwide. Like other coronaviruses, SARS-CoV-2 is thought to have been transmitted to humans from wild animals. Given the scale and widespread geographical distribution of the current pandemic and confirmed cases of cross-species transmission, the question of the extent to which this transmission is possible emerges, as well as what molecular features distinguish susceptible from non-susceptible animal species. Here, we investigated the structural properties of several ACE2 orthologs bound to the SARS-CoV-2 spike protein. We found that species known not to be susceptible to SARS-CoV-2 infection have non-conservative mutations in several ACE2 amino acid residues that disrupt key polar and charged contacts with the viral spike protein. Our models also allow us to predict affinity-enhancing mutations that could be used to design ACE2 variants for therapeutic purposes. Finally, our study provides a blueprint for modeling viral-host protein interactions and highlights several important considerations when designing these computational studies and analyzing their results."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-9796-3193"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Structural Biology, Stanford University School of Medicine, Stanford, California, United States of America."
          }
        ],
        "LastName": "Rodrigues",
        "ForeName": "Jo\u00e3o P G L M",
        "Initials": "JPGLM"
      },
      {
        "Identifier": [
          "0000-0003-4868-6593"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Advanced Chemistry of Catalonia (IQAC), CSIC, Barcelona, Spain."
          }
        ],
        "LastName": "Barrera-Vilarmau",
        "ForeName": "Susana",
        "Initials": "S"
      },
      {
        "Identifier": [
          "0000-0002-9113-0622"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Program in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada."
          }
        ],
        "LastName": "M C Teixeira",
        "ForeName": "Jo\u00e3o",
        "Initials": "J"
      },
      {
        "Identifier": [
          "0000-0003-0195-0094"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "ZIK HALOMEM & Institute of Biochemistry and Biotechnology, Martin Luther University Halle-Wittenberg, Biozentrum, Halle (Saale), Germany."
          }
        ],
        "LastName": "Sorokina",
        "ForeName": "Marija",
        "Initials": "M"
      },
      {
        "Identifier": [
          "0000-0001-5910-649X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California, United States of America."
          }
        ],
        "LastName": "Seckel",
        "ForeName": "Elizabeth",
        "Initials": "E"
      },
      {
        "Identifier": [
          "0000-0002-1463-8422"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "ZIK HALOMEM & Institute of Biochemistry and Biotechnology, Martin Luther University Halle-Wittenberg, Biozentrum, Halle (Saale), Germany."
          }
        ],
        "LastName": "Kastritis",
        "ForeName": "Panagiotis L",
        "Initials": "PL"
      },
      {
        "Identifier": [
          "0000-0002-8414-7397"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Structural Biology, Stanford University School of Medicine, Stanford, California, United States of America."
          }
        ],
        "LastName": "Levitt",
        "ForeName": "Michael",
        "Initials": "M"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R35 GM122543",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS Comput Biol",
    "NlmUniqueID": "101238922",
    "ISSNLinking": "1553-734X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "Angiotensin-Converting Enzyme 2"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "bioRxiv. 2020 Jul 23;:",
      "PMID": "32577636"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "chemistry",
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Angiotensin-Converting Enzyme 2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Binding Sites"
    },
    {
      "QualifierName": [
        "genetics",
        "transmission",
        "veterinary",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Computational Biology"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Conserved Sequence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genetic Predisposition to Disease"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Dynamics Simulation"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [
        "chemistry",
        "metabolism",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "chemistry",
        "metabolism"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Zoonoses"
    }
  ],
  "CoiStatement": "The authors have declared that no competing interests exist."
}